• Explore /
  • Poster
  • / UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602).

UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602).

Abstract Poster

Authors

null

Craig Gedye

Calvary Mater Newcastle, Waratah, Australia

Craig Gedye , David William Pook , Laurence Eliot Miles Krieger , Carole A. Harris , Jeffrey C. Goh , Ganessan Kichenadasse , Howard Gurney , Craig Underhill , Francis Parnis , Anthony M. Joshua , Thomas Ferguson , Felicia Roncolato , Michelle L. Harrison , Michelle Frances Morris , Stephen Begbie , Elizabeth J. Hovey , Mathew George , Prashanth Prithviraj , Elizabeth Chien Hern Liow , Ian D. Davis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03177239

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS768)

Abstract #

TPS768

Poster Bd #

L2

Abstract Disclosures

Similar Posters

First Author: Ciara Conduit

First Author: Craig Gedye

First Author: Geoffrey Thomas Gibney

First Author: Lorenzo Pilla